News & Updates

Show Multimedia Only

Indapamide shows low incidence of severe hypokalaemia in patients with hypertension

30 Mar 2023 by

In a territory-wide, 12-year follow-up retrospective study by the University of Hong Kong, indapamide has demonstrated a low incidence of hospitalization for severe hypokalaemia in patients with hypertension. Use of sustained-release (SR) indapamide appears to lower the risk of severe hypokalaemia vs the immediate-release (IR) formulation.

30 Mar 2023

Regular virgin olive oil intake lowers mortality risk

29 Mar 2023 by

Moderate consumption of virgin olive oil (VOO) daily appears to help reduce the risk of all-cause and cardiovascular mortality, reports a study. However, such effects are not found in common olive oil.

29 Mar 2023

Cardiorespiratory fitness change linked to survival in patients with or without CVD

29 Mar 2023

Changes in cardiorespiratory fitness (CRF) appear to predict the risk of mortality in patients with and without cardiovascular disease (CVD), suggest the results of a study.

29 Mar 2023

HK data: SGLT2 inhibitors cut risks of respiratory and renal diseases in T2DM

29 Mar 2023 by

Sodium-glucose cotransporter 2 (SGLT2) inhibitors reduce the risks of respiratory and renal diseases vs dipeptidyl peptidase-4 (DPP-4) inhibitors in patients with type 2 diabetes mellitus (T2DM), researchers from the University of Hong Kong (HKU) have reported.

29 Mar 2023

No drawback to immediate complete revascularization in ACS

29 Mar 2023 by

Doing an immediate complete revascularization of coronary artery lesions is as safe as a staged complete revascularization approach in patients with acute coronary syndrome (ACS) and multivessel disease in the BIOVASC trial presented at ACC.23/WCC.

29 Mar 2023

Women, minorities remain underrepresented in paediatric cardiology

28 Mar 2023

The presence of women in paediatric cardiology remains inadequate, while that of underrepresented minorities in medicine (URMM) is very limited, reveals a recent study.

28 Mar 2023

Atorvastatin cardioprotective in lymphoma patients receiving anthracycline?

25 Mar 2023 by

Among patients with lymphoma receiving anthracycline-based chemotherapy, those who received atorvastatin for 12 months were significantly less likely to experience a cardiac dysfunction than those on placebo, according to the STOP-CA* trial presented at ACC.23/WCC.

25 Mar 2023

Less salt may be fatally counterproductive for people with heart failure

24 Mar 2023 by

Too little salt is not necessarily better for individuals with heart failure, with the results of a recent meta-analysis suggesting that sodium restriction in this population increases the risk of death.